Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
39 Cards in this Set
- Front
- Back
transmission of HIV
|
only through contact w/infected body fluids: blood, semen, vaginal secretions, breast milk
|
|
pathophysiology of HIV
|
RNA virus binds to specific CD4 (T-cells) and chemokine (protein receptors) enter cell
|
|
Reverse transcriptase
|
enzyme made by retrovirus, assists to make viral DNA from the RNA
|
|
What happens when viral DNA enters cell
|
It enters cell nucleus and splices itself into genome permanantly
|
|
What is the consequence of viral DNA integration into genetic structure
|
All daughter cells are infected; Viral DNA will direct cell to make HIV (a new HIV cell)
|
|
Viremia
|
Large viral levels in the blood usually lasts for 2-3weeks (after initial insult)
|
|
What happens after viremia
|
A prolonged period (could be to 10-12 yrs) of low viral load
|
|
What types of cells are infected
|
Cells w/ CD4 receptor sites: CD4 t-cells, lymphocytes, monocytes, astrocytes, oligodendrocytes
|
|
Healthy/normal T-cells life span
|
about 100 days
|
|
infected T-cells
|
only about 2 days; viral activity kills about 1 billion T-cells daily
|
|
Why does invasion of HIV result in immune dysfunction
|
Mostly do to destruction of CD4 T-cells, which are key cells for immune recognition and defense against pathogens
|
|
Normal T-cell life span
|
100 days
|
|
infected T-cells life span
|
only about 2 days.
Viral activity destroys about 1 billion T-cells daily |
|
Normal T-cell cell count
|
800-1200 cells/μl
|
|
What are the T-cell levels when immune problems start
|
when levels drop below 500 cells/μl
|
|
How long does it take for antibodies to become + for HIV
|
approximately 3 wks - 3 mos
|
|
Acute infection (w/HIV)
|
occurs about 1-3 wks after infection; lasts about 2 wks
|
|
Clinical manifestations of acute infection
|
Flulike symptoms: fever, swollen lymph glands, sore throat, HA, malaise, nausea, muscle & joint pain, diarrhea, or diffuse rash
|
|
Early chronic infection (w/HIV)
|
Point when antibodies become positive for infection, 3wks-3mos after infection. It can last for years. Most are not aware of infected status
|
|
Clinical Manifestations of early chronic infection
|
Generally, pt is asymptomatic, but may display fatigue, HA, low-grade fever, and frequent night sweats
|
|
Intermediate chronic infection (w/HIV)
|
Generally, years after infection. T-cells drop to 200-500 cells/μl & viral load increases. HIV advances to more active state
|
|
Clinical manifestations of intermediate chronic infection
|
Thrush, oral hairy leukoplakia, drenching night sweats, severe fatigue, localized infections
|
|
oral hairy leukoplakia
|
painless lateral lesions on the tongue, Epstein Barre is the etiology
|
|
Late chronic infection
|
AIDS; CD4 levels drop below 200 cells/μl (immune system greatly compromised); great risk for opportunistic disease
|
|
Clinical manifestations of AIDS
|
PCP (fungal infection), non productive cough, fever, chills, undx resp failure, possible wasting & dementia
|
|
Some common opportunistic diseases
|
Pneumocystis jiroveci pneumonia, cryptococcal meningitis, cytomegalovirus retinitis, mycobacterium avium complex, Kaposi sarcoma, influenza
|
|
CDC criteria for dx of AIDS
|
CD4 T-cell count <200 cells/μl, specific opportunistic infection or cancer, wasting syndrome, AIDS dementia complex
|
|
HIV testing
|
EIA blood test is done to detect serum antibodies that bind to HIV antigens.
|
|
Results of EIA test
|
if negative, then reported negative. If positive, the test is repeated, if still positive, a Western blot or immunofluorescence assay is done
|
|
How often should one be tested for HIV
|
If risky behavior, test should be repeated in 3 wks, 6 wks, then 3 mos
|
|
window period
|
the time it takes after infection but before antibodies can be detected in the blood
|
|
How is progression of HIV infection monitored
|
By monitoring CD4 T-cell counts and viral load; abnormal blood tests are common some may reveal neutropenia, thrombocytopenia, and anemia
|
|
COLLABORATIVE care for HIV pt
|
monitor progression & immune function, initiate & monitor antiretroviral therapy, prevent & detect opportunistic infection, prevent & treat complications of therapy, ongoing health assessment
|
|
Main goals of drug therapy for HIV
|
decrease viral load, maintain/raise CD4 counts, delay HIV-related symptoms & opportunistic infections
|
|
action of: Nucleoside reverse transcriptase inhibitors, nonnucleoside transcriptase inhibitors, and nucleotide reverse transcriptase inhibitors
|
work by inhibiting the activity of reverse transcritase (aka inhibit the ability of HIV to make a DNA copy early in replication
|
|
Action of: protease inhibitors
|
interfere with activity of enzyme protease
|
|
Action of: Fusion inhibitors (or entry inhibitors)
|
interfere with HIV CD4 receptor site binding and entry into cells
|
|
combination antiretroviral therapy (ART)
|
three or more drugs from different groups are prescribed at full strength
|
|
Major advantage of ART?
|
attacks the viral replication in several ways, drug resistance is reduced
|